Tool Review

Cognoa Canvas Dx

FDA-authorized AI for autism spectrum disorder diagnosis in children

Support Level
Self-Help
Pricing
Subscription
Platforms
Web
Privacy
Not rated

Best For

  • Pediatricians wanting to screen for autism in-office
  • Health systems reducing autism diagnosis wait times
  • Developmental clinics increasing diagnostic capacity
  • Primary care expanding autism assessment access

Not Recommended For

  • Children outside the 18 month - 6 year age range
  • Standalone diagnosis without clinical oversight (requires provider)
  • Non-clinical direct-to-consumer use
Reviewed by HeyPsych Board· Last reviewed September 2026

About Cognoa Canvas Dx

Cognoa Canvas Dx is a digital therapeutic and mental health measurement tool. FDA-authorized AI for autism spectrum disorder diagnosis in children It is designed for: Pediatricians wanting to screen for autism in-office, Health systems reducing autism diagnosis wait times, Developmental clinics increasing diagnostic capacity.

Get Cognoa Canvas Dx

Privacy & Security

Privacy Grade
Not rated
HIPAA Compliant
No
Data Sold
No

FAQ

About Cognoa Canvas Dx

Canvas Dx is the first FDA-authorized AI-based diagnostic aid for autism spectrum disorder. It helps clinicians diagnose ASD in children ages 18 months to 6 years by combining caregiver questionnaires, video analysis, and provider assessments.